⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IMTX News

Immatics N.V. Ordinary Shares

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps